MiMedx Group, Inc.MDXGNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank29
5Y CAGR-5.2%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
-5.2%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202513.11%
2024160.27%
2023227.73%
2022-273.21%
202184.92%
202017.15%
2019-261.56%
2018-55.22%
2017207.43%
201654.32%